Cingulate Inc. Other Receivables
Cingulate Inc. (CING) had Other Receivables of $19.04 thousand as of 2025-09-30, per its 10-Q filed 2025-11-13.
Financial Statements › Notes › Nontrade Receivables
us-gaap:OtherReceivables · last filed 2025-11-13
- 2025-09-30: Other Receivables $19.04K.
- 2025-06-30: Other Receivables $19.59K.
- 2025-03-31: Other Receivables $41.57K.
- 2024-12-31: Other Receivables $26.32K.
| Period end | Other Receivables |
|---|---|
| 2025-09-30 | $19.04K 10-Q · filed 2025-11-13 |
| 2025-06-30 | $19.59K 10-Q · filed 2025-08-19 |
| 2025-03-31 | $41.57K 10-Q · filed 2025-05-08 |
| 2024-12-31 | $26.32K 10-Q · filed 2025-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |
| iBio, Inc. (IBIO) | United States | $0.077B | -2.94 |